IN2014DN09713A - - Google Patents

Info

Publication number
IN2014DN09713A
IN2014DN09713A IN9713DEN2014A IN2014DN09713A IN 2014DN09713 A IN2014DN09713 A IN 2014DN09713A IN 9713DEN2014 A IN9713DEN2014 A IN 9713DEN2014A IN 2014DN09713 A IN2014DN09713 A IN 2014DN09713A
Authority
IN
India
Prior art keywords
eye
patient
lacrimal
intraocular pressure
punctum
Prior art date
Application number
Other languages
English (en)
Inventor
Deepank Utkhede
Suzanne Cadden
Yong Hao
Original Assignee
Quadra Logic Tech Inc
Deepank Utkhede
Suzanne Cadden
Yong Hao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc, Deepank Utkhede, Suzanne Cadden, Yong Hao filed Critical Quadra Logic Tech Inc
Publication of IN2014DN09713A publication Critical patent/IN2014DN09713A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
IN9713DEN2014 2012-05-03 2014-11-18 IN2014DN09713A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261642287P 2012-05-03 2012-05-03
US201261644397P 2012-05-08 2012-05-08
US201261644401P 2012-05-08 2012-05-08
US201261659921P 2012-06-14 2012-06-14
US201261680641P 2012-08-07 2012-08-07
US201261717615P 2012-10-23 2012-10-23
PCT/IB2013/000694 WO2013164671A1 (en) 2012-05-03 2013-02-27 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension

Publications (1)

Publication Number Publication Date
IN2014DN09713A true IN2014DN09713A (ja) 2015-07-31

Family

ID=49514247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9713DEN2014 IN2014DN09713A (ja) 2012-05-03 2014-11-18

Country Status (7)

Country Link
EP (1) EP2844224B1 (ja)
JP (1) JP6213560B2 (ja)
CN (1) CN105473130A (ja)
CA (1) CA2872338C (ja)
HK (1) HK1222810A1 (ja)
IN (1) IN2014DN09713A (ja)
WO (1) WO2013164671A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021107A2 (en) 2010-08-12 2012-02-16 Nanyang Technological University A liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
GB201714392D0 (en) * 2017-09-07 2017-10-25 Marsteller Laurence Methods and devices for treating glaucoma

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321108A (en) 1965-11-26 1967-05-23 William E Bowe Printing ink dispenser
US3681608A (en) 1971-03-17 1972-08-01 Us Navy Laser beam receiver having a high signal to noise ratio
US4281654A (en) 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4936008A (en) 1988-05-09 1990-06-26 Teledyne Mec Laser striping method for assembling TWT
US4934708A (en) 1988-05-20 1990-06-19 Kolkind Gerald L Family quiz board game
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5259508A (en) 1992-08-27 1993-11-09 Beckerman Stephen M Protective shipping package
EP0664707B1 (en) 1992-10-13 1997-06-04 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
US6622308B1 (en) 1999-03-23 2003-09-16 Scientific-Atlanta, Inc. Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7300364B2 (en) 2004-02-06 2007-11-27 Acushnet Company Multi-layer golf ball having velocity gradient from faster center to slower cover
CA2513443A1 (en) 2003-02-26 2004-09-10 Medivas, Llc Bioactive stents and methods for use thereof
JP4104137B2 (ja) * 2003-05-30 2008-06-18 有限会社エム・エル・シー 涙点プラグ
US7662864B2 (en) 2003-06-04 2010-02-16 Rutgers, The State University Of New Jersey Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
US20050129731A1 (en) 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
DK1704141T3 (en) 2004-01-05 2016-05-02 Nicox Sa Prostaglandin nitrooxyderivatives
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
EP1765454B1 (en) 2004-07-02 2016-04-13 Mati Therapeutics Inc. Treatment medium delivery device for the eye
KR101062796B1 (ko) 2006-03-31 2011-09-06 큐엘티 인코포레이티드 약물 요법을 위한 비루관 배출계 임플란트
KR20090102810A (ko) * 2006-12-26 2009-09-30 큐엘티 플러그 딜리버리, 인코포레이티드 시력 결함을 억제하기 위한 약물 전달 임플란트
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
DK2865361T3 (da) 2007-09-07 2019-07-08 Mati Therapeutics Inc Tåreimplantater og tilhørende fremgangsmåder
CN101861135A (zh) 2007-09-07 2010-10-13 Qlt栓塞输送公司 泪道植入物检测
ES2533359T3 (es) 2007-09-07 2015-04-09 Mati Therapeutics Inc. Núcleos de fármaco para liberación sostenida de agentes terapéuticos
CN102670352A (zh) 2007-09-07 2012-09-19 Qlt股份有限公司 用于泪腺植入物的插入和抽出工具
AU2009244804A1 (en) * 2008-05-09 2009-11-12 Qlt Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
EP2389221B1 (en) 2009-01-23 2023-08-16 Mati Therapeutics Inc. Sustained released delivery of one or more agents
CA2977078C (en) * 2009-02-23 2021-07-20 Mati Therapeutics, Inc. Lacrimal implants and related methods
CA2781629A1 (en) 2009-11-27 2011-06-03 Sascha K. Zarins Lacrimal implants including split and insertable drug core

Also Published As

Publication number Publication date
EP2844224B1 (en) 2018-04-11
HK1222810A1 (zh) 2017-07-14
JP6213560B2 (ja) 2017-10-18
JP2015520628A (ja) 2015-07-23
EP2844224A4 (en) 2016-02-24
CN105473130A (zh) 2016-04-06
EP2844224A1 (en) 2015-03-11
CA2872338A1 (en) 2013-11-07
CA2872338C (en) 2021-09-14
WO2013164671A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
WO2013030679A3 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
MX2018014763A (es) Suministro intraocular de farmacos.
WO2010105130A3 (en) Opthalmic drug delivery system and applications
MX2011007804A (es) Suministro de liberación sostenida de uno o más agentes.
MX2020002381A (es) Implantes intraoculares que contienen prostamida y metodos para su uso.
CA3010374A1 (en) Intraocular pressure reduction with intracameral bimatoprost implants
WO2009105690A3 (en) Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
WO2010093945A3 (en) Uveoscleral drug delivery implant and methods for implanting the same
TW200603775A (en) Anti-excitotoxic sustained release intraocular implants and related methods
WO2012071476A3 (en) Drug eluting ocular implant
WO2014165308A3 (en) Microsphere drug delivery system for sustained intraocular release
MX2010012022A (es) Suministro de liberacion sostenida de agentes activos para tratar glaucoma e hipertension ocular.
EA201590502A1 (ru) Система доставки глазного имплантата
WO2014143754A3 (en) Prostamide-containing intraocular implant
PH12019500423A1 (en) Pharmaceutical composition
WO2012167167A3 (en) Eye shunt with porous structure
WO2012033730A3 (en) Punctal plug containing drug formulation
WO2011084366A3 (en) Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
TWD159201S (zh) 眼內鏡片植入具用鏡片保持引導具之部分
WO2011159761A3 (en) Punctal plugs with continuous or pulsatile drug release mechanism
IN2014DN09713A (ja)
MX2022005063A (es) Tratamiento de enfermedades oculares con antagonistas de receptor de endotelina.
MX2022002306A (es) Metodos de tratamiento de enfermedades oculares con un implante para la administracion sostenida de farmacos.
Richoz et al. Crosslinking for recurrent keratoconus
RU2010135224A (ru) Способ хирургического лечения макулярного отека после факоэмульсификации катаракты